Pharmacokinetics and tolerance of vinorelbine in elderly patients with metastatic breast cancer
Authors:
- R. SorioRSR. Sorio
- I. RobieuxIRI. Robieux
- E. GalligioniEGE. Galligioni
- A. FreschiAFA. Freschi
- A.M. ColussiACA.M. Colussi
- D. CrivellariDCD. Crivellari
- S. SaracchiniSSS. Saracchini
- S. MonfardiniSMS. Monfardini
- 1 February 1997
- journal article
- clinical trial
- Published by Elsevier in European Journal of Cancer
- Vol. 33 (2) , 301-303
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Pharmacokinetics of vinorelbine in patients with liver metastasesClinical Pharmacology & Therapeutics, 1996
- Sensitive high-performance liquid chromatographic method with fluorescence detection for measurement of vinorelbine plasma concentrationsJournal of Chromatography B: Biomedical Sciences and Applications, 1996
- Entry and evaluation of elderly patients in european organization for research and treatment of cancer (EORTC) new-drug–development studiesCancer, 1995
- Vinorelbine is an active antiproliferative agent in pretreated advanced breast cancer patients: a phase II study.Journal of Clinical Oncology, 1994
- Pharmacokinetic, bioavailability, and feasibility study of oral vinorelbine in patients with solid tumors.Journal of Clinical Oncology, 1994
- Relation between age and clearance rate of nine investigational anticancer drugs from phase I pharmacokinetic dataCancer Chemotherapy and Pharmacology, 1994
- Phase II trial of weekly intravenous vinorelbine in first-line advanced breast cancer chemotherapy.Journal of Clinical Oncology, 1993
- Pharmacokinetics of vinorelbine in manEuropean Journal of Clinical Pharmacology, 1992
- Management of Drug Therapy in the ElderlyNew England Journal of Medicine, 1989